Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CareDx, Inc.CDNA · Entity 4344 | Secretary and General Counsel | October 01, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CareDx, Inc.
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 105,078 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Tax withholding · Disposed 997 · Balance 105,078 F1: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 5, 2026 22:49 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 997 | $66.23 | $66,031.31 |
DisclosureSEC source: 0002019976-26-000011 · form4-10052026_101020.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,078 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| August 05, 2026 Filed Aug 6, 2026 20:05 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 500 | $46.75 | $23,375.00 |
DisclosureSEC source: 0002019976-26-000010 · form4-08062026_040804.xml · nonDerivative · entry 2 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,075 F1 · kind: The transaction reported in this row was effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on September 4, 2025. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.59 to $46.94 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 05, 2026 Filed Aug 6, 2026 20:05 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 2,188 | $46.15 | $100,974.45 |
DisclosureSEC source: 0002019976-26-000010 · form4-08062026_040804.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,575 F1 · kind: The transaction reported in this row was effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on September 4, 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.49 to $46.45 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 01, 2026 Filed Aug 4, 2026 23:41 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 2,872 | $47.85 | $137,425.20 |
DisclosureSEC source: 0002019976-26-000009 · form4-08042026_110839.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,763 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:02 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 997 | $29.25 | $29,162.25 |
DisclosureSEC source: 0002019976-26-000007 · form4-07022026_080707.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,635 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| June 06, 2026 Filed Jun 9, 2026 20:05 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 1,292 | $21.95 | $28,359.40 |
DisclosureSEC source: 0002019976-26-000006 · form4-06092026_040601.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,632 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| May 05, 2026 Filed May 6, 2026 20:05 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 2,688 | $20.68 | $55,581.12 |
DisclosureSEC source: 0002019976-26-000005 · form4-05062026_040502.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,924 F1 · kind: The transaction reported in this row was effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on September 4, 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.405 to $21.26 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 01, 2026 Filed May 4, 2026 20:14 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 2,873 | $21.50 | $61,769.50 |
DisclosureSEC source: 0002019976-26-000004 · form4-05042026_080507.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,612 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| April 06, 2026 Filed Apr 7, 2026 20:01 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 1,892 | $17.82 | $33,715.44 |
DisclosureSEC source: 0002019976-26-000003 · form4-04072026_080410.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,485 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:03 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 3,987 | $17.87 | $71,247.69 |
DisclosureSEC source: 0002019976-26-000002 · form4-04032026_080457.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,377 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| February 03, 2026 Filed Feb 4, 2026 21:22 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 4,441 | $20.56 | $91,286.09 |
DisclosureSEC source: 0002019976-26-000001 · form4-02042026_090216.xml · nonDerivative · entry 5 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,364 F5 · kind: The transaction reported in this row was effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on September 4, 2025. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:22 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 2,970 | $20.42 | $60,647.40 |
DisclosureSEC source: 0002019976-26-000001 · form4-02042026_090216.xml · nonDerivative · entry 4 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,805 F4 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of RSUs. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:22 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 2,492 | $20.42 | $50,886.64 |
DisclosureSEC source: 0002019976-26-000001 · form4-02042026_090216.xml · nonDerivative · entry 3 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,775 F3 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of PRSUs. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:22 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 4,342 | $0.00 | $0.00 |
DisclosureSEC source: 0002019976-26-000001 · form4-02042026_090216.xml · nonDerivative · entry 2 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,267 F2 · shares: The reported securities were subject to a performance restricted stock unit ("PRSU") award that was initially granted on February 1, 2025, and were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation and Human Capital Committee of the Issuer's Board of Directors on February 2, 2026. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 21:22 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 33,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002019976-26-000001 · form4-02042026_090216.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,925 F1 · shares: The reported securities are represented by restricted stock units ("RSUs"), of which one-third will vest on April 6, 2027 and the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each of the subsequent eight quarters, rounded down to the nearest whole share until the last such installment, such that one-hundred percent of the RSUs will be vested on the third anniversary of April 6, 2027, subject to the Reporting Person's continuous employment on each applicable vesting date. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 21:07 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 286 | $19.75 | $5,648.36 |
DisclosureSEC source: 0002019976-25-000013 · form4-12052025_091251.xml · nonDerivative · entry 2 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,925 F1 · kind: The transaction reported in this row was effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on September 4, 2025. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.73 to $19.76 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 21:07 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 7,007 | $19.15 | $134,156.02 |
DisclosureSEC source: 0002019976-25-000013 · form4-12052025_091251.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,211 F1 · kind: The transaction reported in this row was effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on September 4, 2025. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.69 to $19.67 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 07, 2025 Filed Nov 10, 2025 21:14 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 2,688 | $15.52 | $41,722.87 |
DisclosureSEC source: 0002019976-25-000012 · form4-11102025_091136.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,218 F1 · kind: The transaction reported in this row was effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on September 4, 2025. Read SEC document |
| November 06, 2025 Filed Nov 7, 2025 22:22 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 2,152 | $15.01 | $32,301.52 |
DisclosureSEC source: 0002019976-25-000011 · form4-11072025_101138.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,906 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| November 01, 2025 Filed Nov 4, 2025 21:03 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 2,872 | $14.77 | $42,419.44 |
DisclosureSEC source: 0002019976-25-000010 · form4-11042025_091159.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,058 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| August 05, 2025 Filed Aug 7, 2025 20:00 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 2,688 | $12.79 | $34,380.60 |
DisclosureSEC source: 0001415889-25-021242 · form4-08072025_080827.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,930 F1 · kind: The transaction reported in this row was effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 19, 2024. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.33 to $13.03 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 20:29 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 2,873 | $12.22 | $35,108.06 |
DisclosureSEC source: 0001415889-25-021035 · form4-08052025_080832.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,618 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| July 07, 2025 Filed Jul 14, 2025 20:01 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 276 | $18.45 | $5,092.20 |
DisclosureSEC source: 0001415889-25-019703 · form4-07142025_080723.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,491 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 20:30 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 2,583 | $19.52 | $50,420.16 |
DisclosureSEC source: 0000950170-25-084373 · ownership.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,767 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| May 05, 2025 Filed May 7, 2025 20:38 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 2,688 | $14.70 | $39,513.60 |
DisclosureSEC source: 0000950170-25-065797 · ownership.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,350 F1 · kind: The transaction reported in this row was effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 19, 2024. Read SEC document |
| May 01, 2025 Filed May 5, 2025 20:53 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 2,873 | $15.07 | $43,296.11 |
DisclosureSEC source: 0000950170-25-063652 · ownership.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,038 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| April 07, 2025 Filed Apr 9, 2025 20:30 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 924 | $17.72 | $16,373.28 |
DisclosureSEC source: 0002019976-25-000006 · wk-form4_1744230605.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,911 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| March 21, 2025 Filed Mar 25, 2025 20:31 UTC | CareDx, Inc. CDNA · Entity 4344 | GrantCommon Stock | 23,158 | $0.00 | $0.00 |
DisclosureSEC source: 0002019976-25-000004 · wk-form4_1742934704.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,835 F1 · shares: The reported securities are represented by restricted stock units, of which one-third will vest on April 1, 2026 and the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each of the subsequent eight quarters, rounded down to the nearest whole share until the last such installment, such that one-hundred percent of the restricted stock units will be vested on the third anniversary of April 1, 2026, subject to the Reporting Person's continuous employment on each applicable vesting date. Read SEC document |
| February 04, 2025 Filed Feb 5, 2025 21:30 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 3,512 | $23.30 | $81,829.25 |
DisclosureSEC source: 0002019976-25-000002 · wk-form4_1738791038.xml · nonDerivative · entry 2 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,677 F2 · kind: The transaction reported in this row was effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 19, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.1000 to $23.7300, inclusive. The Reporting Person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:30 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 2,048 | $23.32 | $47,759.36 |
DisclosureSEC source: 0002019976-25-000002 · wk-form4_1738791038.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,189 F1 · kind: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:32 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 1,917 | $26.00 | $49,842.00 |
DisclosureSEC source: 0002019976-24-000015 · wk-form4_1733520724.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 110,237 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 19, 2024. Read SEC document |
| November 25, 2024 Filed Dec 3, 2024 21:31 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 858 | $24.00 | $20,592.00 |
DisclosureSEC source: 0002019976-24-000014 · wk-form4_1733261453.xml · nonDerivative · entry 5 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,154 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 19, 2024. Read SEC document |
| November 25, 2024 Filed Dec 3, 2024 21:31 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 365 | $24.00 | $8,760.00 |
DisclosureSEC source: 0002019976-24-000014 · wk-form4_1733261453.xml · nonDerivative · entry 4 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 113,012 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 19, 2024. Read SEC document |
| November 18, 2024 Filed Dec 3, 2024 21:31 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 1,071 | $22.00 | $23,562.00 |
DisclosureSEC source: 0002019976-24-000014 · wk-form4_1733261453.xml · nonDerivative · entry 3 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 113,377 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 19, 2024. Read SEC document |
| November 18, 2024 Filed Dec 3, 2024 21:31 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 807 | $22.00 | $17,754.00 |
DisclosureSEC source: 0002019976-24-000014 · wk-form4_1733261453.xml · nonDerivative · entry 2 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 114,448 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 19, 2024. Read SEC document |
| November 18, 2024 Filed Dec 3, 2024 21:31 UTC | CareDx, Inc. CDNA · Entity 4344 | SaleCommon Stock | 3,656 | $21.65 | $79,160.81 |
DisclosureSEC source: 0002019976-24-000014 · wk-form4_1733261453.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,255 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 19, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.34 to $21.94, inclusive. The Reporting Person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 21:35 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 452 | $23.21 | $10,490.92 |
DisclosureSEC source: 0002019976-24-000013 · wk-form4_1731101725.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,911 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:34 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 1,905 | $22.64 | $43,129.20 |
DisclosureSEC source: 0002019976-24-000012 · wk-form4_1730842447.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,363 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 20:40 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 1,905 | $23.58 | $44,919.90 |
DisclosureSEC source: 0002019976-24-000010 · wk-form4_1722890412.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,268 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| July 08, 2024 Filed Jul 10, 2024 20:31 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 183 | $15.59 | $2,852.97 |
DisclosureSEC source: 0002019976-24-000009 · wk-form4_1720643492.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,173 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:30 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 1,713 | $15.42 | $26,414.46 |
DisclosureSEC source: 0002019976-24-000007 · wk-form4_1718051417.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,356 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:44 UTC | CareDx, Inc. CDNA · Entity 4344 | Tax withholdingCommon Stock | 1,905 | $9.18 | $17,487.90 |
DisclosureSEC source: 0002019976-24-000005 · wk-form4_1714769044.xml · nonDerivative · entry 1 Novack Jeffrey Adam · CIK 0002019976 · Secretary and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,069 F1 · shares: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.